LEASE 10900 WILSHIRE, L.L.C., a Delaware limited liability company, Landlord and CHROMADEX, INC., a California corporation, Tenant for 10900 Wilshire Boulevard Los Angeles, California July 6, 2017Lease • March 7th, 2019 • ChromaDex Corp. • Medicinal chemicals & botanical products • California
CHROMADEX CORPORATION EXECUTIVE EMPLOYMENT AGREEMENT for LISA BRATKOVICHExecutive Employment Agreement • March 7th, 2019 • ChromaDex Corp. • Medicinal chemicals & botanical products • California
This Executive Employment Agreement (this “Agreement”) is entered into as of June 1, 2018 (the “Effective Date”), by and between Lisa Bratkovich (“Executive”) and ChromaDex Corporation, a Delaware corporation (the “Company”).
SUPPLY AGREEMENTSupply Agreement • March 7th, 2019 • ChromaDex Corp. • Medicinal chemicals & botanical products • Delaware
THIS SUPPLY AGREEMENT (the "Agreement") is made and entered into as of the 19th of December, 2018 (the “Effective Date”) by and between NESTEC Ltd., a Swiss private limited company, with principal offices located at Avenue Nestle 55, 1800 Vevey, Switzerland ("Buyer" or “NHSc”) and ChromaDex Inc., a California corporation with principal offices located at 10005 Muirlands, Blvd, Suite G, Irvine, CA 92618, USA (“Seller” or “ChromaDex”). Buyer and Seller are individually referred to herein as a “Party” and collectively as the “Parties.”
FIRST AMENDMENT TO LEASETo Lease • March 7th, 2019 • ChromaDex Corp. • Medicinal chemicals & botanical products
This FIRST AMENDMENT TO LEASE (this "First Amendment") is made and entered into as of the 7th day of February, 2018, by and between 10900 WILSHIRE, L.L.C., a Delaware limited liability company ("Landlord"), and CHROMADEX, INC., a California corporation ("Tenant").
THIRD AMENDMENT TO LEASETo Lease • March 7th, 2019 • ChromaDex Corp. • Medicinal chemicals & botanical products
This THIRD AMENDMENT TO LEASE (this "Third Amendment") is made and entered into as of November 9, 2018, by and between 10900 WILSHIRE, L.L.C., a Delaware limited liability company ("Landlord"), and CHROMADEX, INC., a California corporation ("Tenant").
CONSULTANT AGREEMENTConsultant Agreement • March 7th, 2019 • ChromaDex Corp. • Medicinal chemicals & botanical products • California
This Agreement made as of this 20th day of November, 2018, (“Effective Date”) between ChromaDex, Inc. (hereinafter referred to as “ChromaDex”), having its principal offices located 10005 Muirlands Blvd, Suite G, Irvine, CA 92618, and Troy Rhonemus (hereinafter referred to as “Consultant”), with a notice address of 26991 Moro Azul, Mission Viejo CA 92691.
SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • March 7th, 2019 • ChromaDex Corp. • Medicinal chemicals & botanical products • California
THIS SEPARATION AND RELEASE AGREEMENT (the “Agreement”), by and between Troy Rhonemus (the “Employee”) and ChromaDex, Inc. and any parents, subsidiaries, or affiliates of the Company (collectively referred to herein as the “Company”).
SECOND AMENDMENT TO LEASETo Lease • March 7th, 2019 • ChromaDex Corp. • Medicinal chemicals & botanical products
This SECOND AMENDMENT TO LEASE (this "Second Amendment") is made and entered into as of June 30, 2018, by and between 10900 WILSHIRE, L.L.C., a Delaware limited liability company ("Landlord"), and CHROMADEX, INC., a California corporation ("Tenant").
